Tecnotree Reports Impressive Q1 2023 Results with Strong Growth and Increased Profitability
18.4.2023 12:04:00 EEST | Business Wire | Press release
Tecnotree, a global digital platform and services leader for 5G and cloud-native technology, announced its financial results for the first quarter of 2023, demonstrating impressive growth and success. The company has achieved a remarkable 17% growth in net sales, marking its strongest Q1 revenue performance in the past four years. This exceptional growth was primarily driven by the Americas Region, which contributed significantly to Tecnotree's revenue expansion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230418005718/en/
Tecnotree Reports Impressive Q1 2023 Results with Strong Growth and Increased Profitability (Graphic: Business Wire)
Key Q1 Highlights of the financial results:
• Net sales were EUR 15.5 million with a growth of 17.0% as compared to last year
• The operating result was EUR 3.6 million, an increase of 80.5%
• The net result was EUR 1.8 million, an increase of 79.2%
• Order book at the end of the period stood at EUR 67.8 million
• Earnings per share were EUR 0.01
Padma Ravichander, CEO of Tecnotree Corporation, said, “Tecnotree has achieved several significant milestones in the first quarter of 2023, demonstrating its unwavering commitment to innovation, excellence, and customer satisfaction. Our continued growth is fuelled by the increasing demand for our products and solutions, with strong ongoing deliveries of the Digital Stack across the Middle East, Africa, and Europe, and we anticipate receiving increasing orders from new and existing Tier 1 operators. This growth is a result of our continued investment in R&D, particularly in our Tecnotree Sensa AI/ML engineering platform and multi-cloud technologies, which has further cemented our position as a leader in the AI/ML space.”
She further commented, “We're committed to expanding our digital products and services to reach new frontiers in Telco, Healthcare, and Fintech industries in 2023 and beyond. Our Moments platform and Fintech offerings are poised to revolutionize the way digital service providers and ecosystem players collaborate to introduce innovative revenue models and empower digitally connected communities. We're excited to build new partnerships and leverage our expertise to make a significant impact in these new verticals."
Other significant milestones in the Quarter:
- Tecnotree has increased its research and development investments and launched Tecnotree Sensa AI/ML engineering platform, which has been integrated across its digital portfolio for Telecom, Fintech, and Social Commerce segments. The move has enabled the company to enhance its offerings and deliver more value to its customers.
- The company witnessed its highest Q1 growth in net sales and added two new Tier-1 logos from North America, Radian in the USA and Telus in Canada. Furthermore, an existing customer, Claro Peru, expanded its digital portfolio to include Sensa AI for customer 360 experience management. This expansion has helped Tecnotree to strengthen its customer base and position itself as a leader in the industry.
- Tecnotree's profitability has improved, despite increasing its investments in research and development. The company has implemented strong cost-saving measures in its human capital to achieve this, demonstrating its commitment to sustainable growth.
- Tecnotree has been recognized by Gartner’s Market Guide again in Q1 of 2023 for Customer Experience and Management for Telecom Operators and has been consistently recognized for the same since 2020. Additionally, Tecnotree has been recognized by Gartner’s Market Guide for Revenue Monetisation and Management for Telecom Operators consistently since 2020. The recognition reinforces Tecnotree's reputation as a reliable and innovative partner in the industry.
- Tecnotree continues to be among the leading vendors in TM Forum Open APIs certification standards, with 44 APIs certified by the industry standards body, highlighting the company’s commitment to interoperability and collaboration.
- Tecnotree Moments, the company's telecom monetisation platform, has been awarded the Best Telecom Monetisation Platform by the Government of Dubai at the ftNFT Awards. This recognition is a testament to Tecnotree's leadership in cutting-edge technologies and its ability to drive further innovation with humanized AI-enabled experiences.
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree is among the first companies in the world to be Platinum Certified by TM Forum Open API standards, and our agile and open-source Digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on Helsinki Nasdaq (TEM1V).
For more information, please visit www.tecnotree.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230418005718/en/
Contact information
Padma Ravichander, Tecnotree CEO
Email: marketing@tecnotree.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom